EANS-News: Balda Group now with the two operating segments Balda Medical and Balda Technical (with document)
29.01.2013 – 10:45
-------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Company Information/Operating segments Bad Oeynhausen (euro adhoc) - Acquired US companies C. Brewer and HK Plastics Engineering will be integrated into the Group structure - Half-yearly report for 2012/2013 will be published on 20 February 2013 Bad Oeynhausen, 29 January 2013 - Following the integration of C. Brewer Co. and HK Plastics Engineering, Inc., the two US plastics specialists acquired at the end of 2012, the Balda Group will be doing business with the two operating segments - Balda Medical and Balda Technical. The existing Medical segment will be expanded to include the respective healthcare activities of the two acquired companies. It will comprise around 450 employees, who will be based in Bad Oeynhausen and at four plants in California, USA. The segment will be headed by Dr. Rolf Eilers. The previous Electronics Products operating segment will be renamed Balda Technical. In addition to the site at Ipoh, Malaysia, it will also comprise three other sites of C. Brewer and HK Plastics Engineering in California, USA. With a workforce of more than 1,100 employees, this segment will develop, produce and market precision plastic injection molding solutions for high- quality optics, electronics and automotive applications. The segment will be headed by Dominik Müser, the sole member of Balda AG's Management Board. Balda Central Services will remain the Group's third segment. It mainly covers the activities of Balda AG as the Group's strategic and financial holding company and as such is not an operating segment. The Balda Group's new segment structure, which will be introduced with the upcoming report on the first six months (1 July to 31 December 2012) of the current 2012/2013 financial year, is as follows: Balda Medical and Balda Technical are independent and equal segments of the Balda Group, Bad Oeynhausen. Balda Medical comprises the strategic business areas Pharma, Diagnostics and Medical Technology. Around 450 employees work in Bad Oeynhausen in Germany and at the US sites in Anaheim, Ontario, Irvine and Oceanside. The Balda Medical segment is run by Dr. Rolf Eilers. Balda Technical employs around 1,100 people at its production sites in Ipoh (Malaysia) and Anaheim and Irvine (both USA). Balda Technical comprises the strategic business areas Optics, Electronics and Automotive. Balda Technical is managed by Dominik Müser (CEO). In his capacity as Chief Executive Officer, Dominik Müser also manages Balda Central Services, whose staff of eight in Bad Oeynhausen and Amsterdam (The Netherlands) cover the strategic services of corporate communications, capital markets as well as financing and tax. Due to the required integration of the two US acquisitions into the consolidated financial statements of Balda AG, which, among other things, will involve a changeover of the accounting to International Financial Reporting Standards (IFRS), the 2012/2013 half-yearly report will be published on 20 February 2013 and not on 7 February 2013, as previously announced. About Balda Balda is an international producer of high-quality plastics products and system solutions. The company provides superior engineering services, products of the highest quality as well as a fast, flexible and tailored service for its customers. Based in Bad Oeynhausen and operating further production facilities in California, the Balda Medical segment develops and produces high-quality plastics solutions for the medical technology, pharmaceutical and diagnostics markets. The Balda Technical segment comprises products and solutions for the electronics, optics and automotive industries. It operates production facilities in Malaysia and California. The Balda Group generated revenues of EUR 24.7 million in the short financial year 2012 (1 January to 30 June 2012) compared to EUR 66.3 million in calendar year 2011. The Balda share (ISIN: DE0005215107) is listed on the SDAX segment of Deutsche Börse. www.balda.de www.balda-medical.de Attachments with Announcement: ---------------------------------------------- http://resources.euroadhoc.com/us/oRSA5aqX http://resources.euroadhoc.com/us/5wWlCcyy Further inquiry note: Frank Elsner Frank Elsner Kommunikation für Unternehmen GmbH Tel.: +49 - 54 04 - 91 92 0 Fax: +49 - 54 04 - 91 92 29 Mail: office@elsner-kommunikation.de end of announcement euro adhoc -------------------------------------------------------------------------------- Attachments with Announcement: ---------------------------------------------- http://resources.euroadhoc.com/us/oRSA5aqX http://resources.euroadhoc.com/us/5wWlCcyy company: Balda Aktiengesellschaft Bergkirchener Str. 228 D-32549 Bad Oeynhausen phone: +49 (0) 5734 9 22-0 FAX: +49 (0) 5734 922-2604 mail: info@balda.de WWW: http://www.balda.de sector: Semiconductors & active components ISIN: DE0005215107 indexes: SDAX, Prime All Share stockmarkets: free trade: Berlin, München, Hamburg, Düsseldorf, Stuttgart, regulated dealing/prime standard: Frankfurt language: English